Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...

Anti-inflammatory therapies that are highly effective for inflammatory skin diseases might also be relevant to depression ...

Patients with MDD exhibit significantly higher triglyceride levels, which correlate with worse functional impairment scores.

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six prospective controlled studies that included 3,532 ...

Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...

Depression-related fatigue is caused by cellular "overworking" at rest and a failure to produce energy under stress.